BioPharma Credit (LON:BPCR – Get Free Report)’s stock price passed above its 50 day moving average during trading on Thursday. The stock has a 50 day moving average of GBX 0.97 and traded as high as GBX 0.98. BioPharma Credit shares last traded at GBX 0.98, with a volume of 2,361,853 shares trading hands.
BioPharma Credit Price Performance
The stock’s 50 day moving average price is GBX 0.97 and its two-hundred day moving average price is GBX 0.95. The firm has a market capitalization of £11.06 million, a price-to-earnings ratio of 0.10 and a beta of 0.23.
Insider Transactions at BioPharma Credit
In other news, insider Graeme Proudfoot bought 70,000 shares of the stock in a transaction that occurred on Tuesday, September 29th. The shares were acquired at an average cost of GBX 99 per share, for a total transaction of £69,300. Insiders own 0.09% of the company’s stock.
BioPharma Credit Company Profile
BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. The company was incorporated in 2016 and is based in London, the United Kingdom.
Read More
- Five stocks we like better than BioPharma Credit
- Google’s Credit Backstop May Be TeraWulf’s Biggest Advantage
- Could the Midterms Revive Medicare for All? 3 Healthcare Stocks to Watch
- Qualcomm Beat Earnings, But Its Fastest-Growing Businesses Have a Catch
- Oil, Uranium, or Renewables? 3 Energy Plays for a Changing Market
Receive News & Ratings for BioPharma Credit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioPharma Credit and related companies with MarketBeat.com's FREE daily email newsletter.
